Does Delaying Curative Surgery for Colorectal Cancer Influence Long-term Disease Free Survival.
NCT ID: NCT04430231
Last Updated: 2020-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
602 participants
OBSERVATIONAL
2012-01-01
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Organ/Space Surgical Site Infection and Recurrence and Survival in Rectal Cancer Surgery
NCT06382415
Survival Outcome After Minilaparotomy for the Treatment of Colorectal Cancer
NCT03843398
Effects of Anesthetic Techniques on Time to Start of Adjuvant Chemotherapy Following Surgery for Colorectal Cancer
NCT04493905
A Multicenter Clinical Trial on Laparoscopic Colorectal Cancer Surgery Compared With Open Surgery
NCT02248038
Colon Cancer Surgery in the Aged; Postoperative Outcome, Functional Recovery and Survival.
NCT03904121
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and Methods A prospective, single center study was carried out in patients with stage I-III colorectal cancer scheduled for surgery between 2012-2017 at a Colorectal Surgery Unit of a tertiary care center. Wait list time was defined as the time from completion of diagnostic workup and definitive surgery and divided into 2-week intervals from 2 to 6 weeks. The outcome variables were 2- and 5-year disease free survival. Screening for disease progression was with carcinoembryonic antigen levels and chest/abdominal computed tomography scan. Data was collected prospectively and subsequently analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wait list time 0-2 weeks
Wait list time 0-2 weeks
Wait list time
Wait list time 2-4 weeks
Wait list time 2-4 weeks
Wait list time
Wait list time 4-6 weeks
Wait list time 4-6 weeks
Wait list time
Wait list time > 6 weeks
Wait list time \> 6 weeks
Wait list time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wait list time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With "colon" or "upper rectum" as their primary site of malignancy according to International Classification of Diseases for Oncology, Third Edition topography code.
Exclusion Criteria
* More than one primary site,
* Synchronous metastasis or peritoneal carcinomatosis at the time of surgery
* If they received neoadjuvant chemoradiotherapy
* If they had a local transanal excision.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación para la Investigación del Hospital Clínico de Valencia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephanie Garcia Botello
Clinical Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/285
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.